glendale glp-1 ✨ Semaglutide vs. Tirzepatide: What’s the Difference? 🤔✨, Both are effective medications for weight loss, but Tirzepatide takes it further with dual action, targeting both GLP-1 & GIP receptors GLP-1 Supplement for Weight Management

A Research Study Investigating Semaglutide in People With Early Alzheimers Disease (EVOKE) ClinicalTrials.gov Identifier: NCT04777396

After 40 weeks, tirzepatide significantly outperformed placebo in both glycemic control and weight loss

GLP-1(2836) augments glucose utilization, decreases FAO, and activates sAC through MTP

Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)

Patients on GLP-1 therapy who reduce food intake dramatically without attention to nutritional quality are at higher risk for these gaps